We are live on ! Find out more
FMS icon

Fresenius Medical Care

135 hedge funds and large institutions have $573M invested in Fresenius Medical Care in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 59 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more call options, than puts

Call options by funds: $740K | Put options by funds: $384K

38% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 13

4% more funds holding

Funds holding: 130135 (+5)

1% more capital invested

Capital invested by funds: $569M → $573M (+$4.6M)

0.51% less ownership

Funds ownership: 5.68%5.17% (-0.51%)

51% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 59

Holders
135
Holders Change
+5
Holders Change %
+3.85%
% of All Funds
3.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
29
Reduced
59
Closed
13
Calls
$740K
Puts
$384K
Net Calls
+$356K
Net Calls Change
-$9.44M
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$3.25M -$1.65M -49,059 -35%
COPPSERS
27
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.16M -$342K -10,199 -10%
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$3.08M -$36.6K -1,090 -1%
FA
29
FDx Advisors
Illinois
$2.98M -$349K -10,410 -11%
TAM
30
Trillium Asset Management
Massachusetts
$2.68M +$42.4K +1,264 +2%
BFIM
31
Beese Fulmer Investment Management
Ohio
$2.64M -$39.9K -1,190 -2%
Renaissance Technologies
32
Renaissance Technologies
New York
$2.6M -$1.09M -32,600 -31%
Morgan Stanley
33
Morgan Stanley
New York
$2.54M -$173K -5,161 -7%
Citigroup
34
Citigroup
New York
$2.44M -$721K -21,492 -24%
MAM
35
Martingale Asset Management
Massachusetts
$2.38M
HJGA
36
Hardman Johnston Global Advisors
Connecticut
$2.35M -$6.34M -188,990 -74%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$2.26M +$2.18K +65 +0.1%
MCM
38
McKinley Capital Management
Alaska
$2.25M +$2.13M +63,364 New
Bank of America
39
Bank of America
North Carolina
$2.07M -$296K -8,820 -13%
HC
40
Highmount Capital
New York
$1.91M +$49.6K +1,480 +3%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$1.84M -$571K -17,030 -25%
PI
42
Putnam Investments
Massachusetts
$1.67M
Fifth Third Bancorp
43
Fifth Third Bancorp
Ohio
$1.61M -$528K -15,731 -26%
RFC
44
Regions Financial Corp
Alabama
$1.59M +$306K +9,136 +26%
BFM
45
Boston Financial Management
Massachusetts
$1.58M -$30.7K -914 -2%
WAM
46
World Asset Management
Michigan
$1.53M -$409K -12,194 -22%
CAM
47
Capstone Asset Management
Texas
$1.52M -$22.1K -660 -2%
KAM
48
Keeley Asset Management
Illinois
$1.44M +$16.1K +480 +1%
Jane Street
49
Jane Street
New York
$1.38M +$614K +18,308 +89%
GT
50
Glenmede Trust
Pennsylvania
$1.33M -$344K -10,251 -22%

FMS Hedge Fund Activity: Q4 2013 in Review

135 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Fresenius Medical Care (FMS) for Q4 2013, worth a combined $573M — up 0.81% from $569M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new FMS positions and 13 closed out — a net gain of 5 holders — while 29 added to existing stakes and 59 trimmed.

The largest buyer was State Farm Mutual Automobile Insurance, opening a new position worth an estimated $4.22M. The largest seller was Marathon Asset Management (UK), cutting an estimated $10.9M.

  • 135 institutional investors held Fresenius Medical Care (FMS) as of Q4 2013, up from 130 in Q3 2013.
  • Funds reported $573M of Fresenius Medical Care stock for Q4 2013, up 0.81% quarter-over-quarter.
  • 18 funds opened new Fresenius Medical Care positions in Q4 2013 and 13 closed out, a net change of +5 holders.
  • The largest Fresenius Medical Care buyer in Q4 2013 was State Farm Mutual Automobile Insurance, an estimated $4.22M added.
  • The largest Fresenius Medical Care seller in Q4 2013 was Marathon Asset Management (UK), an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2013.